Great Novel Therapeutics Biotech & Medicals (7427.TWO)

TWD 32.85

(-18.69%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Total Assets 644.84 Million 372.84 Million 229.96 Million 125.85 Million 85.67 Million
Total Current Assets 485.45 Million 251.45 Million 125.4 Million 67.16 Million 13.51 Million
Cash And Short Term Investments 476.55 Million 247.57 Million 125.1 Million 67.02 Million 13.5 Million
Cash and Cash Equivalents 179.55 Million 111.07 Million 62.78 Million 67.02 Million 24.87 Million
Short Term Investments 297 Million 136.5 Million 62.31 Million - 13.5 Million
Net Receivables 564 Thousand - - - 1.00
Inventory 6.16 Million - - - 17 Thousand
Other Current Assets 2.17 Million 3.77 Million 233 Thousand 137 Thousand 3.14 Million
Total Non-Current Assets 159.39 Million 121.39 Million 104.55 Million 58.69 Million 44.13 Million
Net PPE 16.01 Million 116 Thousand 118 Thousand 807 Thousand 829 Thousand
Good Will And Intangible Assets 112.75 Million 99.41 Million 88.6 Million 48.23 Million 38.65 Million
Good Will 83.59 Million 84.14 Million - - -
Intangible Assets 29.15 Million 15.27 Million 88.6 Million 48.23 Million 38.65 Million
Long-Term Investments - - - - -
Tax Assets - - - - -
Other Non Current Assets 30.63 Million 21.86 Million 15.83 Million 9.64 Million 4.65 Million
Other Assets - - - - 28.02 Million
Total Liabilities 26.81 Million 12.04 Million 21.6 Million 5.3 Million 18.67 Million
Total Current Liabilities 15.93 Million 12.04 Million 21.6 Million 5.3 Million 18.67 Million
Account Payables 623 Thousand 833 Thousand 860 Thousand 76 Thousand 188 Thousand
Tax Payables - - - - -
Short Term Debt 3.49 Million 833 Thousand 860 Thousand 76 Thousand -
Deferred Revenue -623 Thousand -833 Thousand -860 Thousand -76 Thousand -
Other Current Liabilities 12.43 Million 11.21 Million 20.74 Million 5.22 Million 18.48 Million
Total Non Current Liabilities 10.88 Million - - - -
Long-Term Debt 10.88 Million - - - -
Deferred Revenue Non Current - - - - -
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities - - - - -
Other Liabilities - - - - -
Total Equity 618.03 Million 360.8 Million 208.35 Million 120.54 Million 67 Million
Stock Holders Equity 618.03 Million 360.8 Million 208.35 Million 120.54 Million 67 Million
Common Stock 383.57 Million 292.86 Million 225.75 Million 185.75 Million 142.65 Million
Retained Earnings -356.65 Million -295.11 Million -239.33 Million -203.48 Million -172.21 Million
Accumulated other comprehensive income - - - - -
Common Stock Equity 618.03 Million 360.8 Million 208.35 Million 120.54 Million 67 Million
Capital Lease Obligation 13.75 Million - - - -
Total Investments 297 Million 136.5 Million 62.31 Million - 13.5 Million
Total Debt 14.37 Million 833 Thousand 860 Thousand 76 Thousand -
Net Debt -165.17 Million -110.24 Million -61.92 Million -66.94 Million -24.87 Million

Balance Sheet Charts